Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
High blood biomarkers for Alzheimer’s disease found by the newly FDA approved blood test indicate the presence of two proteins in the brain called amyloid and tau. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says some …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Let’s say you’ve taken the newly approved blood test for Alzheimer’s disease and the results indicate the presence of tau and amyloid in your brain, so you’re at risk. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says …
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
A new blood test for Alzheimer’s disease isn’t a stand alone diagnostic tool. That’s according to Abhay Moghekar, a blood biomarkers expert and a neurologist at Johns Hopkins. Moghekar: You would still need the clinical input in the context of …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Will an FDA cleared blood test for Alzheimer’s disease ease or complicate diagnosis? Clearly in approving the test the FDA hopes for the former, yet the complete picture is more complex than that, says Abhay Moghekar, a blood biomarkers expert …
Biomarkers alone don’t mean Alzheimer’s disease is present, Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Positive results on the newly FDA cleared blood test for Alzheimer’s disease don’t necessarily mean you have the disease. That’s according to blood biomarkers expert Abhay Moghekar, a neurologist at Johns Hopkins. Moghekar: Whether that's the cause of your cognitive …
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
The FDA has just cleared a blood test to help make the diagnosis of Alzheimer’s disease, which otherwise may require some fairly invasive methods. Blood biomarkers expert Abhay Moghekar, a neurologist at Johns Hopkins, says the test looks for the …
